Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Medpace Holdings, Inc.

NASDAQ: MEDP · Industrial Applications and Services · 6 alerts · CIK 1668397

Share price
$648.20Close, Nov 16
Market cap
$18.1B
Shares outstanding
27.97MLatest SEC cover page
Sector
Industrial Applications and Services
Industry
Services-Commercial Physical & Biological ResearchSIC 8731

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Medpace Holdings, Inc. filings on SEC EDGAR ↗

6:25 PM ET Form 4
Insider Selling

Medpace Holdings General Counsel & Corp. Secy. Stephen P. Ewald Sells $859K of Stock

Stephen P. Ewald, General Counsel & Corp. Secy., sold 1,245 shares of Medpace Holdings, Inc. at $690.00 a share, worth $859K in total on Oct 29, 2026. Shares held after the trade: 19,098 (-6.1%).

Value
$859K
Shares
1,245
Price
$690.00
Role
General Counsel & Corp. Secy.
Holding change
-6.1%
Trade date
Oct 29, 2026
4:23 PM ET Form 4
Insider Selling

Medpace Holdings Exec. VP, Operations Susan E. Burwig Sells $13.5M of Stock

Susan E. Burwig, Exec. VP, Operations, sold 20,000 shares of Medpace Holdings, Inc. at $677.00 a share, worth $13.5M in total between Oct 26, 2026 and Oct 27, 2026. Shares held after the trade: 54,012 (-6.8%).

Value
$13.5M
Shares
20,000
Average price
$677.00
Role
Exec. VP, Operations
Holding change
-6.8%
Trade date
Oct 26, 2026 to Oct 27, 2026
4:03 PM ET 10-Q
Financial Results

Medpace Holdings Q3 2026 Results: Net Income $137M, Up 23.7% YoY

Medpace reported net income of $137.5 million for the third quarter of 2026, up from $111.1 million in the prior year period, driven by an 8.5% increase in net revenue to $716.0 million. For the nine months ended September 30, 2026, net cash provided by operating activities remained strong at $530.4 million, while the company continued its share repurchase program, spending $294.8 million year-to-date.

Key figure
Net income $137M · +23.7% YoY
4:17 PM ET 8-K
Financial Results

Medpace Holdings Financial Results

Medpace reported Q3 2026 revenue of $716.0 million, an 8.5% increase year-over-year, and GAAP net income of $137.5 million ($4.84 per diluted share). Alongside the results, the Board authorized a new $1.0 billion stock repurchase program effective through December 2028, replacing the previous authorization which had $527.0 million remaining.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.